WATERTOWN, Mass. - 生物制药公司Disc Medicine, Inc. (NASDAQ:IRON)宣布了其针对非透析依赖性慢性肾病(NDD-CKD)和贫血患者的DISC-0974 Phase 1b研究的新发现。在美国肾脏病学会肾脏周上公布的研究结果显示，单剂量DISC-0974显著降低了患者的铁蛋白水平，并改善了铁的动员和血红蛋白水平。 这项正在进行的研究包括2-5期NDD-CK ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

Dr. Marjorie Jenkins, a professor of internal medicine and former dean of the University of South Carolina School of Medicine ...

GE HealthCare expands its medical imaging equipment production in Waukesha with its first North American manufacturing site ...

周三，Jefferies分析师给予Disc Medicine（NASDAQ:IRON）股票"买入"评级，目标价定为89.00美元。这家专注于血液疾病的临床阶段生物技术公司目前正在推进其主要药物候选者bitopertin的研发，这是一种GlyT1抑制剂，旨在治疗罕见血液疾病红细胞生成性原卟啉症（EPP）。 该公司已报告了二期试验的总体支持性结果，并正准备在2024年第四季度与FDA举行二期末（EOP ...

The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade.

WVU Medicine Children's and the Cook Center for Human Connection have teamed with an former NFL quarterback's association to ...

Zumbro Valley Medical Society's street medicine program is holding a dermatology and foot care clinic at Christ United ...

Rare diseases often cause unexplainable medical symptoms that can be exhausting, infuriating, and deadly. Baylor College of ...

A Professor of Hematology and Stem Cell Transplantology at the University of Benin Teaching Hospital, UBTH, Nosakhare Godwin ...

周三，Editas Medicine (EDIT.US)股价走低，截至发稿，下跌2.58%，报3.205美元。消息面上， 富国银行 分析师Yanan Zhu维持对Editas Medicine的等权重评级，并将目标价从27美元降至9美元。

China has unveiled plans to reinforce the development of doctoral programmes in the fields of science, engineering, ...